Lyell Immunopharma, Inc. (LYEL) reported Q3 Revenue

Lyell Immunopharma, Inc. (NASDAQ: LYEL) reported Q3 Revenue for the quarter came in at $34 thousand versus the consensus estimate of $0 .

For earnings history and earnings-related data on Lyell Immunopharma, Inc. (LYEL) click here.

You May Also Be Interested In

• McCormick & Co. (MKC) Tops Q2 EPS by 10c ; Offers Guidance
• Hyperscale Data assets equal roughly 100% of its market cap
• Global S&P Futures mixed in premarket